NCT01443715

Brief Summary

It is challenging for depressed adolescents and their families to access specialized mental health services. A viable option is delivering treatment in the primary care clinic (PCC) setting; however, few effective models are currently available. The overall aim of this study is to assess in the pediatric PCC, the preliminary acceptability and feasibility of a novel collaborative stepped care model of treatment for depressed adolescents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for phase_2 major-depressive-disorder

Timeline
Completed

Started Sep 2011

Typical duration for phase_2 major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 30, 2011

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

September 4, 2014

Status Verified

April 1, 2013

Enrollment Period

2.8 years

First QC Date

September 28, 2011

Last Update Submit

September 2, 2014

Conditions

Keywords

MDDDysthymiaDepressive Disorder Not Otherwise Specified (DDNOS)

Outcome Measures

Primary Outcomes (1)

  • Feasibility based on proportionality

    The investigators will demonstrate the feasibility of the model by calculating the proportion of: 1) adolescent who attend SCIPT-A sessions, 2) adolescents stepped to Phase II who attend their pediatric appointments for medication management, 3) adolescents in Phase II who accepted and followed the medication treatment recommendation, 4) social workers' who were willing and able to learn the SCIPT-A model as demonstrated by displaying fidelity to the treatment model.

    Up to 16 weeks

Secondary Outcomes (1)

  • The proportion of adolescents who agree to be randomized and enrolled in the study protocol

    Up to 16 weeks

Study Arms (2)

Stepped Care IPT-A - Interpersonal Psychotherapy

EXPERIMENTAL

IPT-A focuses on communication and problem-solving skills.

Behavioral: Stepped Care IPT-A (SCIPT-A)

Treatment as Usual

ACTIVE COMPARATOR

Treatment as Usual is the standard treatment received in the community

Behavioral: Treatment as Usual

Interventions

Interpersonal Psychotherapy for adolescents (IPT-A) is a guideline based treatment with established efficacy focusing on reducing depression symptoms and current interpersonal problems associated with depression.

Stepped Care IPT-A - Interpersonal Psychotherapy

Standard treatment in the community

Treatment as Usual

Eligibility Criteria

Age13 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Males and females ages 13-20 years
  • English and Spanish speaking adolescent
  • Parent may be monolingual or bilingual in Spanish
  • DSM-IV diagnosis of Major Depressive Disorder, dysthymia, or Depressive Disorder Not Otherwise Specified
  • Moderate impairment in functioning
  • Moderate depression severity
  • Willing to refrain from other medications unless provided by investigator or PCP during the study

You may not qualify if:

  • Diagnoses of Post Traumatic Stress Disorder , Obsessive Compulsive Disorder, current Substance abuse, Schizophrenia, bipolar disorder, Conduct disorder, Active eating disorder, Pervasive Developmental Disorder, Autism, Asberger's, Psychosis
  • Engagement in severe self-injurious behavior in past 3 months
  • Active suicidal ideation with plan or intent
  • Mental retardation or severe learning disability
  • Medical illness that may interfere with treatment
  • Open Administration for Children's Services (ACS) case
  • Pregnancy
  • Already receiving psychotherapy or medication treatment for depression or have begun a medication trial for another diagnosis within the previous three months
  • History of intolerance to fluoxetine or escitalopram
  • Failed 2 completely adequate and documented Antidepressant trials
  • Co-morbid Attention Deficit Hyperactivity Disorder if not on stable dose of stimulants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York State Psychiatric Institute

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Depressive Disorder, MajorDysthymic Disorder

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Laura Mufson, Ph.D.

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2011

First Posted

September 30, 2011

Study Start

September 1, 2011

Primary Completion

June 1, 2014

Study Completion

July 1, 2014

Last Updated

September 4, 2014

Record last verified: 2013-04

Locations